Clinical Trial Update: Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of Phase 1/2 trials evaluating hyaluronic acid as a treatment to promote bone repair in alveolar bone loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss

Drugs mentioned

• Hyaluronic acid (hyaluronic acid)

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Alveolar Bone Loss | Phase 1, Phase 2 | Status: COMPLETED